Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium [...]

Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

Peer-reviewed paper highlights pain-free enzymatic approach for venous leg ulcers [...]

Carta Healthcare has secured $18.25 million in Series B1 financing [...]